Enrico Brunetta

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

François-Xavier Lescure, Hitoshi Honda, Robert Fowler et al. · The Lancet Respiratory Medicine · 2021 · 248 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy

Maurizio Cecconi, Daniele Piovani, Enrico Brunetta et al. · Journal of Clinical Medicine · 2020 · 196 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +17

Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19

Simin Florescu, Delia Stanciu, Mihaela Zaharia et al. · JAMA · 2022 · 151 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19

Enrico Brunetta, Marco Folci, Barbara Bottazzi et al. · Nature Immunology · 2020 · 148 citations · Full text

Veterinary Medicine, Immunology, Pathology +15

The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer–cell subsets associated with high levels of HIV-1 viremia

Enrico Brunetta, Manuela Fogli, Stefania Varchetta et al. · Blood · 2009 · 144 citations · Full text

Life Sciences, Immunology, Infectious Diseases +10